Tealwood Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,143
Closed -$1.33M 131
2025
Q1
$1.33M Buy
19,143
+4,807
+34% +$397K 0.62% 77
2024
Q4
$1.23M Buy
14,336
+220
+2% +$23.8K 0.51% 98
2024
Q3
$1.68M Buy
14,116
+116
+0.8% +$15.5K 0.74% 60
2024
Q2
$2M Sell
14,000
-77
-0.5% -$10.2K 1.2% 37
2024
Q1
$1.81M Sell
14,077
-8,297
-37% -$988K 0.81% 50
2023
Q4
$2.31M Sell
22,374
-688
-3% -$68K 1.11% 25
2023
Q3
$2.1M Sell
23,062
-202
-0.9% -$17.8K 1.08% 25
2023
Q2
$1.88M Sell
23,264
-332
-1% -$27.1K 0.91% 39
2023
Q1
$1.88M Sell
23,596
-962
-4% -$68.2K 0.96% 34
2022
Q4
$1.66M Sell
24,558
-702
-3% -$41.2K 0.87% 35
2022
Q3
$1.26M Sell
25,260
-58
-0.2% -$3.11K 0.68% 60
2022
Q2
$1.41M Sell
25,318
-242
-0.9% -$13.4K 0.7% 52
2022
Q1
$1.42M Buy
25,560
+102
+0.4% +$5.24K 0.6% 68
2021
Q4
$1.43M Buy
+25,458
New +$1.38M 0.57% 82

Other funds holding NVO

Tealwood Asset Management's NVO Position: Q2 2025 in Review

Tealwood Asset Management sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 19,143 shares — an estimated $1.33M sold.

Tealwood Asset Management first reported a position in NVO in Q4 2021 and held it in 14 quarters. The position peaked at $2.31M in Q4 2023. 1,482 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Tealwood Asset Management reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Tealwood Asset Management sold 19,143 Novo Nordisk shares in Q2 2025, an estimated $1.33M.
  • Tealwood Asset Management first reported a position in Novo Nordisk in Q4 2021 and held it in 14 quarters.
  • Tealwood Asset Management's Novo Nordisk position peaked at $2.31M in Q4 2023.
  • 1,482 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Tealwood Asset Management's 13F filing for Q2 2025, filed 17 Jul 2025.